Pregnant Patients Commonly Report Hesitancy, Lack Of Awareness Toward RSV Immunization Products, Study Finds

Infectious Disease Advisor (8/1, Basilio) reported a study found that “hesitancy and lack of awareness toward respiratory syncytial virus (RSV) immunization products are common among pregnant individuals, suggesting interventions are needed to highlight the safety and effectiveness of RSV products to increase uptake.” Study investigators observed that “intended uptake of the RSVpreF vaccine was more commonly reported by participants who viewed the vaccine as effective and important for RSV prevention. In contrast, older gestational age was inversely associated with intended vaccine uptake.” Researchers noted that “primary reasons for hesitancy toward the RSVpreF vaccine reported among the population included concerns about its effect on infants (74.5%), potential adverse effects (62.8%), the vaccine being ‘too new’ (42.5%), and the safety of vaccines overall (20%). Participants with hesitancy toward the use of nirsevimab reported similar concerns.” The study was published in The Pediatric Infectious Disease Journal.